StocksA › AEXAF

Atos SE (AEXAF) — Earnings Call X-Ray

Our AI read all 25 of AEXAF's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q4 2024 · sign up to see
Previous Call Grade
C
Q3 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
25
2016–2025
Avg Candor
6.5/9
evasion 3.4/9
High CandorCritic AmmunitionMargins ContractingDemand SlowingCutting HeadcountReads RehearsedQuestion Left HangingResults Worse Than Direction

Call-by-call analysis

🔒 Q4 2024 earnings call 2025-03-05 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q4 2024 call grade is ready
The full 37-point AI read of AEXAF's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C Q3 2024 earnings call 2024-10-24

Management held guidance steady against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: slowingMargins: contractingBacklog: shrinkingHeadcount: cutting 1 analysts · 3 questions
⚑ Critic ammunition⚑ Question left hanging✓ Resolves doubts⚑ Reads rehearsedDirection beats results
Candor 7/9
Specificity 7/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 4/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C Q2 2024 earnings call 2024-08-02

Management held guidance steady against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: slowingMargins: contractingBacklog: shrinkingHeadcount: flatCapex: increasing 2 analysts · 5 questions
⚑ Critic ammunition✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead⚑ Reads rehearsedDirection beats results
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 7/9
Uncertainty 3/9
Promotion 5/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q1 2024 earnings call 2024-04-27

Management lowered guidance against slowing demand and contracting margins. The delivery was rich in specifics, visibly under pressure.

Guidance: loweredDemand: slowingMargins: contractingBacklog: shrinkingPricing: under pressureHeadcount: cutting 2 analysts · 3 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsed
Candor 6/9
Specificity 7/9
Evasion 3/9
Confidence 4/9
Uncertainty 7/9
Promotion 3/9
Stress 6/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q4 2023 earnings call 2024-03-26

Management withdrew guidance against mixed demand signals and expanding margins. The delivery was rich in specifics, frequently evasive, visibly under pressure.

Guidance: withdrawnDemand: mixedMargins: expandingBacklog: shrinkingPricing: stableHeadcount: cuttingCapex: decreasing 4 analysts · 14 questions
⚑ Critic ammunition⚑ Question left hangingDirection beats results
Candor 5/9
Specificity 7/9
Evasion 6/9
Confidence 4/9
Uncertainty 8/9
Promotion 4/9
Stress 7/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q4 2023 earnings call 2024-02-29

Management held guidance steady against steady demand and expanding margins. The delivery was unusually candid, rich in specifics, visibly under pressure.

Guidance: maintainedDemand: stableMargins: expandingBacklog: growing 1 analysts · 3 questions
⚑ Critic ammunition⚑ Question left hanging
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 5/9
Uncertainty 6/9
Promotion 2/9
Stress 6/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q3 2023 earnings call 2023-10-26

Management held guidance steady against mixed demand signals. The delivery was rich in specifics.

Guidance: maintainedDemand: mixedMargins: stableBacklog: growingPricing: raisingHeadcount: cutting 4 analysts · 12 questions
⚑ Critic ammunition⚑ Question left hanging✓ Early product, fast growthHidden segmentDirection beats results
Candor 6/9
Specificity 7/9
Evasion 5/9
Confidence 6/9
Uncertainty 4/9
Promotion 4/9
Stress 5/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q2 2023 earnings call 2023-07-28

Management raised guidance against steady demand and expanding margins. The delivery was rich in specifics.

Guidance: raisedDemand: stableMargins: expandingBacklog: growingHeadcount: cuttingCapex: decreasing 3 analysts · 10 questions
⚑ Critic ammunition⚑ Question left hangingHidden segmentDirection beats results
Candor 5/9
Specificity 7/9
Evasion 4/9
Confidence 6/9
Uncertainty 5/9
Promotion 5/9
Stress 5/9
Complexity 8/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q4 2022 2023-03-01 D maintainedacceleratingexpanding 6/9 4/9
Mar 2022 2022-03-01 F noneslowingcontracting 7/9 3/9
Q3 2021 2021-10-21 C maintainedmixedexpanding 6/9 4/9
Q2 2021 2021-07-28 D maintainedmixedcontracting 7/9 4/9
Q4 2020 2021-02-19 D maintainedacceleratingexpanding 6/9 5/9
Q2 2020 2020-07-27 C+ maintainedstablecontracting 7/9 3/9
Q4 2019 2020-02-19 C+ maintainedmixedexpanding 7/9 3/9
Q3 2019 2019-10-26 B+ maintainedacceleratingstable 7/9 3/9
Q1 2019 2019-07-28 B+ maintainedmixedexpanding 8/9 1/9
Q3 2018 2018-10-23 D loweredmixedstable 7/9 3/9
Q4 2017 2018-02-21 C+ maintainedacceleratingexpanding 6/9 3/9
Q3 2017 2017-10-27 C+ raisedmixedexpanding 7/9 3/9
Q2 2017 2017-07-26 B+ maintainedacceleratingexpanding 6/9 2/9
Q4 2016 2017-02-22 C+ maintainedacceleratingexpanding 7/9 4/9
Q3 2016 2016-10-20 C maintainedacceleratingstable 6/9 5/9
Jul 2016 2016-07-26 B+ raisedacceleratingexpanding 7/9 3/9
Q1 2016 2016-04-21 C+ maintainedacceleratingexpanding 6/9 3/9

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAP · Advance Auto Parts, Inc.ABCAF · Athabasca Minerals, Inc.ABDC · Alcentra Capital'sABMD · Abiomed, Inc.ABNRY · ABN AMRO Bank N.V.ABOS · Acumen Pharmaceuticals,

AEVA   All “A” companies    AEXAY

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.